Drug Topics
FEBRUARY 2, 2024
Investigators found that the non-pharmacological interventions were significantly effective at improving HbA1c, quality of life, anxiety, and blood glucose.
Pharmacy Times
FEBRUARY 2, 2024
Supplementation during pregnancy also reduced communication warning behaviors in children who developed autism compared to the children of women who did not take supplements.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
FEBRUARY 2, 2024
Although diabetes mortality rates were stable in the Americas over the past 2 decades, the actual number of diabetes-related deaths is rising.
Pharmacy Times
FEBRUARY 2, 2024
The diabetes/weight loss drug is be evaluated in trials for pediatric patients who are at least 10 years of age.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
FEBRUARY 2, 2024
The vaccine showed an overall efficacy of 80% in the per-protocol analysis, with a risk reduction of 6.1 typhoid infections per 1000 vaccinated children.
Pharmacy Times
FEBRUARY 2, 2024
However, different recommendations may actually be valuable, as different countries have different population-based needs.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
FEBRUARY 2, 2024
Older adults, patients with weakened immune systems, individuals living in long-term facilities, and those with underlying cardiopulmonary disease are at a higher risk of developing severe RSV infection outcomes.
STAT
FEBRUARY 2, 2024
Apple Vision Pro, the company’s most important new product in a decade, promises to envelop consumers in an immersive world of interactive content while employing clever technologies to make the device more usable and less alienating than virtual reality headsets that have come before it. Marketing for Vision Pro has focused on the $3,499, 1.3-pound helmet’s potential for watching video, making work calls, viewing family photos, and other casual uses.
Fierce Pharma
FEBRUARY 2, 2024
Mark your calendars, oncology drug and CAR-T therapy developers. | Mark your calendars, oncology drug and CAR-T therapy developers. The FDA has decided on a date for a highly anticipated advisory committee meeting for Bristol Myers' Abecma and J&J's Carvykti.
STAT
FEBRUARY 2, 2024
Who among us is looking forward to getting older in 2024? Not senators (most of whom are 65 and older ), the two leading presidential candidates (100% of whom are over 75), or the eight Cabinet members who are already more than 65 (growing to 10 in February). Members of the U.S. House of Representatives are younger (averaging 58 years of age ), but even so, many are already over 65.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
FEBRUARY 2, 2024
Pharmacists can heighten awareness about cardiovascular health and promote heart-healthy lifestyles.
STAT
FEBRUARY 2, 2024
ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund. The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.
Fierce Healthcare
FEBRUARY 2, 2024
Lurie Children’s Hospital of Chicago has been working through a “cybersecurity matter” since Wednesday that has led the organization to take its phone, email and Epic MyChart systems offline, accor | Illinois' largest pediatric care provider said it took down its systems preemptively on Wednesday, leading to disruptions across its hospital and other locations.
STAT
FEBRUARY 2, 2024
Since the 1920s , lead vests and aprons have served as trusted shields against the harmful effects of X-rays for radiologists, technicians, and patients. But new safety guidelines from the American Dental Association (ADA) call for discontinuing their use among patients, both because X-ray technology has evolved significantly over the years, and because there are better ways to reduce patients’ exposure to radiation, such as using digital as opposed to conventional X-ray film.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
FEBRUARY 2, 2024
The pandemic acted as a catalyst, propelling virtual care to the forefront of healthcare delivery. | The pandemic acted as a catalyst, propelling virtual care to the forefront of healthcare delivery.
STAT
FEBRUARY 2, 2024
Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy, is now a cautionary tale in pharmaceutical history. This week Biogen said it would no longer sell or study the medicine , which first won approval in 2021, ending an era for one of biotech’s storied companies and leaving the rest of the industry to piece together the lessons of a would-be blockbuster that never took off.
Pharmacy Times
FEBRUARY 2, 2024
Daratumumab and hyaluronidase-fihj in combination with other therapies was previously approved by the FDA in May 2020 for 8 indications in multiple myeloma.
STAT
FEBRUARY 2, 2024
Chicago pediatric hospital Lurie Children’s has been forced to take its network offline in the face of a “cybersecurity matter” as experts warn of heightened threats against health systems across the country. Late Thursday, Lurie Children’s Hospital, which uses Epic System’s electronic health record software, said it was “actively responding” to the issue and working with experts and law enforcement.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
FEBRUARY 2, 2024
As AbbVie slogs through sharp revenue declines for Humira, the company is looking to the immunology light at the end of the tunnel. | Sales of Humira—which once sat pretty as the world’s best-selling drug—plunged nearly 41% to $3.3 billion in the third quarter.
STAT
FEBRUARY 2, 2024
Myopia, or near-sightedness, is on the rise: Nearly half of the world’s population will be nearsighted by 2050, according to the World Health Organization. The condition is increasingly common among children in particular, which ophthalmologists attribute to a combination of less time spent outdoors and more time spent with iPads and iPhones.
Fierce Pharma
FEBRUARY 2, 2024
In his first earnings call as Bristol Myers Squibb’s CEO, Chris Boerner laid out his plan to quickly navigate the company through a period filled with patent cliffs and new government-man | In his first earnings call as Bristol Myers Squibb’s CEO, Chris Boerner laid out his plan to quickly navigate the company through a transition period filled with patent cliffs and new government-mandated pricing pressure.
Fierce Healthcare
FEBRUARY 2, 2024
Optum Perks is rolling out a new telehealth solution that aims to make it easier for patients to secure their prescriptions at a low cost. | Optum Perks is rolling out a new telehealth solution that aims to make it easier for patients to secure their prescriptions at a low cost.
pharmaphorum
FEBRUARY 2, 2024
Learn more about Katherine Stueland, the CEO of GeneDx, as she discusses her journey, the future of diagnostics, whilst at JP Morgan 2024.
Pharmaceutical Commerce
FEBRUARY 2, 2024
A dive into this market reveals that the latest numbers yield promising results—a global value of a worldwide $1.6 trillion—but it will continue to be attributed to past, present, and future healthcare spending.
The FDA Law Blog
FEBRUARY 2, 2024
By Steven J. Gonzalez & Allyson B. Mullen — On January 31, 2024, FDA announced its intent to initiate the reclassification process for most in vitro diagnostic (IVD) products that are currently class III (high risk) into class II (moderate risk). Most of these reclassified tests will supposedly be infectious disease and companion diagnostic IVDs.
STAT
FEBRUARY 2, 2024
WASHINGTON — A bipartisan group of senators released a draft of legislation to resolve controversial disputes in the 340B drug discount program, according to documents obtained by STAT. The drug discount program, which was designed to support providers that serve low-income patients, has been increasingly contentious as it’s grown in recent years.
Fierce Healthcare
FEBRUARY 2, 2024
When Florida Blue announced this week that it’s partnering with Sanitas Medical Center in Jacksonville to deliver primary care, officials with the company considered it in keeping with a healthcare | Among the primary care services to be offered at Sanitas Medical Center in Jacksonville are onsite pharmacy dispensing, chronic condition management, mental health services, labs and imaging.
pharmaphorum
FEBRUARY 2, 2024
Indian pharma Hikma has agreed a $150 million settlement to resolve lawsuits claiming that it helped fuel to the opioid crisis in the US
Fierce Healthcare
FEBRUARY 2, 2024
Renton, Washington-based Providence has cut a deal to refund or erase $157.7 million in medical care payments following allegations and a lawsuit from its home state’s attorney general that the lar | The nonprofit health system's deal with the Washington State Attorney General over allegations it billed patients who may have qualified for charity care is "the largest resolution of its kind in the country.
Fierce Pharma
FEBRUARY 2, 2024
One day after Roche said it was starting to establish Vabysmo as th | One day after Roche said it was starting to establish Vabysmo as the new standard of care in age-related macular degeneration (AMD) and diabetic macular edema (DME), Regeneron clapped back with the same claim about its new treatment—high-dose Eylea.
PharmaVoice
FEBRUARY 2, 2024
Explosive demand for weight loss drugs has propelled both companies to new heights. Here’s a look at the staggering growth, by the numbers.
pharmaphorum
FEBRUARY 2, 2024
Our round-up of recent biotech financings is headed by a $250 million public offering for late clinical-stage biotech Vera Therapeutics, with an initial public offering (IPO) filed by CAR-T specialist Kyverna and private rounds for Eyconis, COUR Pharmaceuticals, Basking Biosciences, Enterprise Therapeutics, Halia Therapeutics and NeoPhore.
STAT
FEBRUARY 2, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. Today, we talk about how biomanufacturing is getting a huge boost in North Carolina, study a new potential root for autoimmune disease in women, and more.
Expert insights. Personalized for you.
209 
Let's personalize your content